Skip to main content

Day: April 13, 2023

Casa Systems Extends Market Leadership with Next Gen Distributed Access Architecture Deployments

Groundbreaking software design sets new benchmarks for performance and flexibility ANDOVER, Mass., April 13, 2023 (GLOBE NEWSWIRE) — Casa Systems (Nasdaq: CASA) today announced that its innovative DA2200 Distributed Access node, the only FPGA-based, DOCSIS 4.0-ready Remote PHY (RPHY) node in the industry, has been successfully deployed with Tier 1 cable operators in North and South America. Setting new industry benchmarks for performance and flexibility, Casa Systems’ DA2200 Distributed Access node provides cable operators with a flexible foundation that enables a smooth, cost-effective transition to distributed, cloud-native environments. Casa Systems’ Distributed Access Architecture (DAA) solutions are designed to help operators push capacity to the edge by improving the services their subscribers enjoy and extracting more value...

Continue reading

Thumzup® Hosting Client Showcase at the Venice Art Crawl on April 20, 2023

Thumzup Media Corporation VACAPRIL23 Venice Art CrawlAvailable in the App Store and Google Play, Thumzup Enables Virtually Everyone to Earn Cash Rewards for Posting on Social Media about the Brands They Love Los Angeles, CA, April 13, 2023 (GLOBE NEWSWIRE) — Thumzup Media Corporation (“Thumzup” or the “Company”) (OTCQB: TZUP) is excited to announce it will be hosting a client showcase as part of the Venice Art Crawl at Belle’s Beach House on April 20, 2023 from 6:00 to 10:00pm PDT. Belle’s Beach House is located at 24 Windward Ave, Venice, CA 90291. The Thumzup mobile app, which is available for download in the App Store and Google Play, incentivizes virtually everyone to become social media advocates for the brands they enjoy by paying them cash for approved posts. Thumzup Media Showcase Hosted by Belles...

Continue reading

Royalty Pharma to Announce First Quarter 2023 Financial Results on May 9, 2023

NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its first quarter 2023 financial results on Tuesday, May 9, 2023 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/news-and-events/events to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company’s website for at least 30 days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating...

Continue reading

Teck Board of Directors Unanimously Rejects Revised Unsolicited Proposal from Glencore

Glencore’s revised proposal is materially unchanged and still not in best interest of Teck Board recommends shareholders vote FOR separation and dual class amendment VANCOUVER, British Columbia, April 13, 2023 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced that its Board of Directors has reviewed and unanimously rejected a revised unsolicited acquisition proposal from Glencore plc, received on April 11, 2023, which would see that company acquire Teck. Consistent with its fiduciary duties and in consultation with its financial and legal advisors, Teck’s Board of Directors (the “Board”) conducted a detailed review and assessment of the revised unsolicited proposal and, on the recommendation of the independent Special Committee of the Board, determined that the revised proposal...

Continue reading

Society Pass Inc. (Nasdaq: SOPA)’s Travel Platform, NusaTrip, Acquires Vietnam’s VLeisure, Marks Its First Acquisition Outside of Indonesia

Society Pass Incorporated Dennis Nguyen, Society Pass Founder, Chairman and Chief Executive Officer and NusaTrip Chairman (on left) and Phan Le, VLeisure Founder and Managing Director (on right)JAKARTA, Indonesia, April 13, 2023 (GLOBE NEWSWIRE) — via NewMediaWire — NusaTrip (“NusaTrip”), a leading Jakarta-based, IATA-licensed Online Travel Agency (“OTA”) and the travel vertical of Society Pass Inc. (Nasdaq: SOPA), Southeast Asia’s (SEA) next generation, data-driven, loyalty, fintech and e-commerce ecosystem, today announces the acquisition of VLeisure, a Ho Chi Minh City, Vietnam-based online B2B hotel platform servicing small-to-medium size hotels in Vietnam and empowering online and offline travel agencies to manage and distribute travel products and services. The VLeisure acquisition extends NusaTrip’s base of operations...

Continue reading

Wejo and TKB file Form S-4 Registration Statement for Business Combination

Wejo Takes Next Steps Towards Full Capitalization MANCHESTER, United Kingdom and EL SEGUNDO, Calif., April 13, 2023 (GLOBE NEWSWIRE) — Wejo Group Limited (NASDAQ: WEJO) (“Wejo”), a global leader in Smart Mobility for Good™ and cloud and software analytics for connected, electric and autonomous vehicle data, and TKB Critical Technologies 1 (NASDAQ: USCT) (“TKB”), a special purpose acquisition company, today announced that they had filed with the U.S. Securities and Exchange Commission (“SEC”) a registration statement on Form S-4, which contains a preliminary proxy statement/prospectus (the “S-4”), in connection with their previously announced business combination. Wejo also announced that it had filed the first amendment to its previously filed shelf registration statement on Form S-3 (the “S-3”). Wejo and TKB...

Continue reading

Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy

BlueCross BlueShield of Mississippi Latest to Allow Non-Physician Practitioners to Prescribe TMS MALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced a healthcare policy update from BlueCross BlueShield (BCBS) of Mississippi that allows TMS trained healthcare professionals to order and provide transcranial magnetic stimulation (TMS) treatment to their patients with major depressive disorder (MDD). This policy change increases access for patients to the Company’s NeuroStar® Advanced Therapy for Mental Health. “It’s heartening to see the momentum from payers that are recognizing the need for broader mental...

Continue reading

Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism

OncoBay Clinical is a boutique clinical research organization (CRO) that is a subsidiary of the Moffitt Cancer Center and has extensive experience in oncology drug development BRIDGEWATER, N.J., April 13, 2023 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company developing therapeutic candidates targeting drug resistant and devastating cancers using ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death, and immuno-oncology targeted novel biologics, has selected immune-oncology clinical research organization (CRO), OncoBay Clinical, to provide comprehensive clinical and regulatory support for the clinical development program for its lead drug candidate HSB-1216. HSB-1216, Hillstream’s most advanced candidate,...

Continue reading

Conduent Features Global Medical Information Services at DIA Medical Affairs and Scientific Communications Conference

Company to present special session on value of centralizing medical information functions to reduce costs and operational complexity; improve satisfaction for consumers and healthcare professionals FLORHAM PARK, N.J., April 13, 2023 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT), a global technology-led business solutions and services company, will showcase its Global Medical Information Services at the DIA Medical Affairs and Scientific Communications Forum, April 17-19, 2023 in Anaheim, Calif. The forum provides education and information about the regulatory and compliance environment affecting the work of medical affairs and scientific communication professionals. At the conference, Conduent will highlight the effectiveness of its AI-driven Medical Information Services to enhance the speed and efficiency with which...

Continue reading

PodcastOne’s LadyGang and Baby Mamas No Drama Receive 2023 Webby Award Nominations

LadyGang’s Live Episode Received Over 6 Million Views and Impressions Combined Across Video, Audio and Social, Exhibiting Over 2,000% Growth From 2021 Webby Online Voting Open Through April 20, 2023, Winners to Be Announced April 25, 2023 LOS ANGELES, CA, April 13, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – PodcastOne, a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), announced today that two of its top performing and long running podcasts LadyGang hosted by Keltie Knight, Jac Vanek and Becca Tobin, and Baby Mamas No Drama hosted by Kail Lowry and Vee Rivera, have received prestigious 2023 Webby Award nominations. “The hosts of LadyGang – Keltie, Jac and Becca, along with Kail and Vee from Baby Mamas No Drama are among the hardest working people in the podcast industry. Their dedication to their...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.